Multiple-Dose Study of Effect of Bardoxolone Methyl on QT/QTC Interval Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

179

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Healthy Volunteers

Interventions

DRUG

Bardoxolone Methyl 20mg

Oral

DRUG

Bardoxolone Methyl 80mg

Oral

DRUG

Bardoxolone Methyl Placebo

Oral

DRUG

Moxifloxacin 400mg

Oral

DRUG

Moxifloxacin Placebo

Oral

Trial Locations (1)

Spaulding Clinical Research, LLC, West Bend